We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLBL
826
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
| $120K | ﹤0.01% |
+18,027
| New | +$175K |
|
|
FNFG
827
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $118K | ﹤0.01% |
11,594
-14,194
| -55% | -$135K |
|
|
FTR
828
DELISTED
Frontier Communications Corp.
FTR
| $117K | ﹤0.01% |
+1,638
| New | +$124K |
|
829
Cousins Properties
CUZ
$5.19B
| $114K | ﹤0.01% |
+4,380
| New | +$121K |
|
|
TIVO
830
DELISTED
Tivo Inc
TIVO
| $112K | ﹤0.01% |
+10,682
| New | +$129K |
|
|
EPE
831
DELISTED
EP Energy Corporation
EPE
| $110K | ﹤0.01% |
+21,325
| New | +$161K |
|
|
SSI
832
DELISTED
Stage Stores Inc
SSI
| $108K | ﹤0.01% |
+11,016
| New | +$158K |
|
833
Corcept Therapeutics
CORT
$12.4B
| $106K | ﹤0.01% |
+28,188
| New | +$143K |
|
834
Mueller Water Products
MWA
$3.95B
| $104K | ﹤0.01% |
13,631
-16,354
| -55% | -$140K |
|
835
PDF Solutions
PDFS
$1.93B
| $103K | ﹤0.01% |
+10,268
| New | +$129K |
|
|
AFFX
836
DELISTED
Affymetrix Inc
AFFX
| $103K | ﹤0.01% |
+12,082
| New | +$121K |
|
837
Geron
GERN
$828M
| $101K | ﹤0.01% |
+36,671
| New | +$133K |
|
|
KZ
838
DELISTED
KongZhong Corporation
KZ
| $98K | ﹤0.01% |
14,900
-500
| -3% | -$3.4K |
|
|
TUES
839
DELISTED
Tuesday Morning Corp
TUES
| $93K | ﹤0.01% |
17,119
+3,651
| +27% | +$32.2K |
|
840
CALL
Marvell Technology
MRVL
$168B
| $91K | ﹤0.01% |
10,000
+8,000
| +400% | +$91.2K |
|
|
SVU
841
DELISTED
SUPERVALU Inc.
SVU
| $87K | ﹤0.01% |
1,728
-3,914
| -69% | -$225K |
|
|
ACG
842
DELISTED
AllianceBernstein Income Fund Inc
ACG
| $87K | ﹤0.01% |
+11,081
| New | +$85.8K |
|
|
UCTT
843
Ultra Clean Holdings
UCTT
$3.73B
| $71K | ﹤0.01% |
+12,300
| New | +$81.2K |
|
844
Teck Resources
TECK
$29.6B
| $69K | ﹤0.01% |
+14,400
| New | +$102K |
|
|
PDLI
845
DELISTED
PDL BioPharma, Inc.
PDLI
| $67K | ﹤0.01% |
+13,400
| New | +$76.8K |
|
|
ODP
846
CALL
DELISTED
ODP
ODP
| $64K | ﹤0.01% |
+1,000
| New | +$77.9K |
|
847
Sabesp
SBS
$19.1B
| $63K | ﹤0.01% |
84,051
-279,561
| -77% | -$251K |
|
848
SiriusXM
SIRI
$9.97B
| $63K | ﹤0.01% |
1,694
-116
| -6% | -$4.45K |
|
849
Ezcorp Inc
EZPW
$1.83B
| $62K | ﹤0.01% |
10,100
-6,393
| -39% | -$40.5K |
|
850
Tronox
TROX
$932M
| $60K | ﹤0.01% |
13,700
-1,800
| -12% | -$16.7K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.